Carregant...
Vaccine adjuvants as potential cancer immunotherapeutics
Accumulated evidence obtained from various clinical trials and animal studies suggested that cancer vaccines need better adjuvants than those that are currently licensed, which include the most commonly used alum and incomplete Freund’s adjuvant, because of either a lack of potent anti-tumor immunit...
Guardat en:
| Publicat a: | Int Immunol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4922024/ https://ncbi.nlm.nih.gov/pubmed/27006304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/intimm/dxw015 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|